Five years have elapsed since the Chinese government announced its ambitious health care reform programme. The fact that both the United States and China unfolded their gigantic national health care reforms almost simultaneously is reflective of the daunting health policy challenges that most national governments are grappling with. While Obamacare has barely survived the obstruction from Congress and remains controversial, its Chinese counterpart has concluded its first phase at a fairly smooth pace. Having had three trillion RMB invested into it within five years, this landmark reform stands out as one of the biggest health policy interventions in modern history in terms of both scale and scope. A critical juncture in the reform process has been reached and it is time to assess its performance to date. This book provides an interim evaluation of China’s ongoing national health care reform from interdisciplinary perspective. Insights generated are not only valuable to inform next phase of the reform, but also relevant to health policy reformers in other developing and transitional countries.
This book was published as a special issue of the Journal of Asian Public Policy.
Table of Contents
1. Introduction: An interim interdisciplinary evaluation of China’s national health care reform: emerging evidence and new perspectives Alex Jingwei He and Qingyue Meng
2. Reallocating authority in the Chinese health system: an institutional perspective Jiwei Qian
3. Has China’s new health care reform improved efficiency at the provincial level? Evidence from a panel data of 31 Chinese provinces Shaolong Wu, Chunxiao Wang and Guoying Zhang
4. Inequality in social health insurance programmes in China: A theoretical approach Sen Tian, Qin Zhou and Jay Pan
5. Too little, but not too late? Health reform in rural China and the limits of experimentalism Kerry Ratigan
6. The development of rural primary health care in China’s health system reform Xiaoyun Liu, Shichao Zhao, Minmin Zhang, Dan Hu and Qingyue Meng
7. The impact of China’s Zero-Markup Drug Policy on county hospital revenue and government subsidy levels Zhongliang Zhou, Yanfang Su, Benjamin Campbell, Zhiying Zhou, Jianmin Gao, Qiang Yu, Jiuhao Chen and Yishan Pan
Alex Jingwei He is the Associate Head of the Department of Asian and Policy Studies at the Hong Kong Institute of Education. He co-edits the Journal of Asian Public Policy. He specializes in health policy and reforms with particular reference to East Asia.
Qingyue Meng is a leading expert in health policy and economics. He has widely published in prestigious journals and publishing houses. He is the Dean of School of Public Health at Peking University, Beijing, China, and a key health policy advisor to the Chinese government.